Paper37720779
Recent Advancements of Aptamers in Cancer Therapy.
Venkatesan S and 2 others. ACS Omega, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Recent Advancements of Aptamers in Cancer Therapy. Papers, record 37720779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37720779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22844652 | Copper-Catalyzed Azide-Alkyne Click Chemistry for Bioconjugation. | Curr Protoc Chem Biol | 2011 | https://conductscience.org/library/papers/22844652 | PubMed |
| 2 | 36603108 | Aptamer-Based Immunotheranostic Strategies. | Cancer Biother Radiopharm | 2023 | https://conductscience.org/library/papers/36603108 | PubMed |
| 3 | 25677591 | Aptamers and their applications in nanomedicine. | Small | 2015 | https://conductscience.org/library/papers/25677591 | PubMed |
| 4 | 27093485 | A simple and rapid detection assay for peptides based on the specific recognition of aptamer and signal amplification of hybridization chain reaction. | Biosens Bioelectron | 2016 | https://conductscience.org/library/papers/27093485 | PubMed |
| 5 | 36270405 | Selective light-up of dimeric G-quadruplex forming aptamers for efficient VEGF165 detection. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36270405 | PubMed |
| 6 | 31981657 | Evaluating single-domain antibodies as carriers for targeted vaccine delivery to the small intestinal epithelium. | J Control Release | 2020 | https://conductscience.org/library/papers/31981657 | PubMed |
| 7 | 20129770 | Nanomaterial-assisted aptamers for optical sensing. | Biosens Bioelectron | 2010 | https://conductscience.org/library/papers/20129770 | PubMed |
| 8 | 37139427 | Recent progress of aptamer‒drug conjugates in cancer therapy. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/37139427 | PubMed |
| 9 | 25414727 | Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells. | J RNAi Gene Silencing | 2014 | https://conductscience.org/library/papers/25414727 | PubMed |
| 10 | 26242462 | A unique aptamer-drug conjugate for targeted therapy of multiple myeloma. | Leukemia | 2016 | https://conductscience.org/library/papers/26242462 | PubMed |
| 11 | 33540523 | Recent Advances in Aptamer Sensors. | Sensors (Basel) | 2021 | https://conductscience.org/library/papers/33540523 | PubMed |
| 12 | 36985529 | Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles. | Molecules | 2023 | https://conductscience.org/library/papers/36985529 | PubMed |
| 13 | 34760167 | Polyvalent spherical aptamer engineered macrophages: X-ray-actuated phenotypic transformation for tumor immunotherapy. | Chem Sci | 2021 | https://conductscience.org/library/papers/34760167 | PubMed |
| 14 | 29617327 | Applications of Cancer Cell-Specific Aptamers in Targeted Delivery of Anticancer Therapeutic Agents. | Molecules | 2018 | https://conductscience.org/library/papers/29617327 | PubMed |
| 15 | 19253922 | Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. | Chembiochem | 2009 | https://conductscience.org/library/papers/19253922 | PubMed |
| 16 | 24483627 | Automated modular synthesis of aptamer-drug conjugates for targeted drug delivery. | J Am Chem Soc | 2014 | https://conductscience.org/library/papers/24483627 | PubMed |
| 17 | 23630258 | Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23630258 | PubMed |
| 18 | 28767098 | Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28767098 | PubMed |
| 19 | 23688339 | Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe. | ACS Chem Biol | 2013 | https://conductscience.org/library/papers/23688339 | PubMed |
| 20 | 29937498 | Potential Inherent Stimulation of the Innate Immune System by Nucleic Acid Aptamers and Possible Corrective Approaches. | Pharmaceuticals (Basel) | 2018 | https://conductscience.org/library/papers/29937498 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42794659 | Molecular Engineering of Aptamers for Glioblastoma Therapy: From Simple Antagonists to AI-Driven Approaches, a Narrative Review. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42794659 | PubMed |
| 42677038 | Artificial Intelligence Integration With Nanotechnology for Cancer Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42677038 | PubMed |
| 42179151 | Evaluation of Photophysical Properties and Biological Applications of Diarylmethanes. | ChemistryOpen | 2026 | https://conductscience.org/library/papers/42179151 | PubMed |
| 41931849 | Aptamers in cancer therapy: Why has clinical translation lagged behind preclinical promise? | Biomed Pharmacother | 2026 | https://conductscience.org/library/papers/41931849 | PubMed |
| 40867568 | Aptamer-Coated PLGA Nanoparticles Selectively Internalize into Epithelial Ovarian Cancer Cells In Vitro and In Vivo. | Biomolecules | 2025 | https://conductscience.org/library/papers/40867568 | PubMed |
| 40699700 | Perturbation-Theory Machine Learning for Multi-Target Drug Discovery in Modern Anticancer Research. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699700 | PubMed |
| 40524931 | Anti-IL-4Rα aptamer reduces IL-4 signalling and formation of nasal polyps. | ERJ Open Res | 2025 | https://conductscience.org/library/papers/40524931 | PubMed |
| 40321580 | Replication Features of SARS-CoV-2 and Advantages of Targeting S Protein with Aptamers to Block Viral Entry. | ACS Omega | 2025 | https://conductscience.org/library/papers/40321580 | PubMed |
| 40125439 | Wolf in Sheep's Clothing: Taming Cancer's Resistance with Human Serum Albumin? | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40125439 | PubMed |
| 40034705 | Aptamer based immunotherapy: a potential solid tumor therapeutic. | Front Immunol | 2025 | https://conductscience.org/library/papers/40034705 | PubMed |
| 39991031 | Revolutionizing Cancer Immunotherapy: Emerging Nanotechnology-Driven Drug Delivery Systems for Enhanced Therapeutic Efficacy. | ACS Meas Sci Au | 2025 | https://conductscience.org/library/papers/39991031 | PubMed |
| 39329537 | Developing New Peptides and Peptide-Drug Conjugates for Targeting the FGFR2 Receptor-Expressing Tumor Cells and 3D Spheroids. | Biomimetics (Basel) | 2024 | https://conductscience.org/library/papers/39329537 | PubMed |
| 38852276 | Inhibition of STAT3: A promising approach to enhancing the efficacy of chemotherapy in medulloblastoma. | Transl Oncol | 2024 | https://conductscience.org/library/papers/38852276 | PubMed |
| 38675202 | Aptamers for the Delivery of Plant-Based Compounds: A Review. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38675202 | PubMed |
| 38256938 | Aptamers' Potential to Fill Therapeutic and Diagnostic Gaps. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38256938 | PubMed |
| 38255292 | Aptamer-Based Smart Targeting and Spatial Trigger-Response Drug-Delivery Systems for Anticancer Therapy. | Biomedicines | 2024 | https://conductscience.org/library/papers/38255292 | PubMed |
| 37958473 | Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958473 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| FGFR4 | 2264 | PubTator's text mining | https://conductscience.org/library/genes/2264 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| PTK7 | 5754 | PubTator's text mining | https://conductscience.org/library/genes/5754 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| TNFRSF13C | 115650 | PubTator's text mining | https://conductscience.org/library/genes/115650 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37720779
GET https://conductscience.org/api/papers/v1/37720779/references?page=2